Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digoxin -- quinidine interaction.

P R Reid, A G Meek

    The Johns Hopkins Medical Journal
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Adding quinidine to digoxin therapy significantly increases digoxin levels, potentially enhancing its effects. Careful monitoring is crucial when using these drugs together to avoid toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.

    Circulation·1999
    Same author

    Breast radiotherapy and lymphedema.

    Cancer·1999
    Same author

    American Cancer Society Lymphedema Workshop. Workgroup I: Treatment of the axilla with surgery and radiation--preoperative and postoperative risk assessment.

    Cancer·1999
    Same author

    A rapid colour stabilization technique for radiochromic film dosimetry.

    Physics in medicine and biology·1998
    Same author

    Androgen induction of urokinase gene expression in LNCaP cells is dependent on their interaction with the extracellular matrix.

    Cancer letters·1998
    Same author

    Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA lung clearance.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1997
    Same journal

    An approach to the management of dementia syndromes.

    The Johns Hopkins medical journal·1982
    Same journal

    Torsion dystonia.

    The Johns Hopkins medical journal·1982
    Same journal

    The Rieger syndrome: a heritable disorder associated with glaucoma.

    The Johns Hopkins medical journal·1982
    Same journal

    Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

    The Johns Hopkins medical journal·1982
    Same journal

    Surgical therapy of complex partial epilepsy.

    The Johns Hopkins medical journal·1982
    Same journal

    Toxic epidermal necrolysis.

    The Johns Hopkins medical journal·1982
    See all related articles

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Cardiology

    Background:

    • Digoxin is a common treatment for atrial fibrillation.
    • Quinidine is an antiarrhythmic medication.
    • Concurrent use of digoxin and quinidine requires careful consideration due to potential drug interactions.

    Observation:

    • A patient on maintenance digoxin for atrial fibrillation experienced a rapid, threefold increase in serum digoxin levels after initiating quinidine therapy.
    • Changes in serum digoxin levels correlated with alterations in the PR interval.
    • Lowering digoxin dosage upon reinstitution, alongside quinidine, achieved stable levels, but discontinuing quinidine alone caused digoxin levels to drop.

    Findings:

    • Quinidine significantly elevates serum digoxin levels.

    Related Experiment Videos

  • Increased digoxin concentrations correlated with enhanced electrophysiologic effects.
  • The interaction between quinidine and digoxin is clinically significant.

    • Implications:

    • Concurrent administration of quinidine and digoxin necessitates cautious monitoring of serum digoxin levels.
    • This interaction may lead to digoxin toxicity if not managed properly.
    • Understanding this drug interaction is vital for optimizing patient safety and therapeutic outcomes in cardiovascular pharmacotherapy.